Orthopediatrics (KIDS) Cash from Investing Activities Growth (1y) (2017 - 2026)
Orthopediatrics (KIDS) Cash from Investing Activities Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -208.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -397.90% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -514.25% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -187.82% |
| 10 | Orthopediatrics | 468.25 Mn | 454.01 Mn | 43.39 Mn | 36.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.75% |
| Dec 31, 2025 | -200.95% |
| Sep 30, 2025 | -0.26% |
| Jun 30, 2025 | -118.00% |
| Mar 31, 2025 | -62.73% |
| Dec 31, 2024 | -113.46% |
| Sep 30, 2024 | -376.87% |
| Jun 30, 2024 | 208.09% |
| Mar 31, 2024 | -111.39% |
| Dec 31, 2023 | 177.16% |
| Sep 30, 2023 | 109.30% |
| Jun 30, 2023 | -3,351.33% |
| Mar 31, 2023 | 125.90% |
| Dec 31, 2022 | -883.37% |
| Sep 30, 2022 | -3,313.90% |
| Jun 30, 2022 | 69.39% |
| Mar 31, 2022 | 355.09% |
| Dec 31, 2021 | 105.02% |
| Sep 30, 2021 | -136.34% |
| Jun 30, 2021 | 53.70% |